[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2000027881A3 - Menschliche interleukin -10 mutantenproteine - Google Patents

Menschliche interleukin -10 mutantenproteine Download PDF

Info

Publication number
WO2000027881A3
WO2000027881A3 PCT/EP1999/008421 EP9908421W WO0027881A3 WO 2000027881 A3 WO2000027881 A3 WO 2000027881A3 EP 9908421 W EP9908421 W EP 9908421W WO 0027881 A3 WO0027881 A3 WO 0027881A3
Authority
WO
WIPO (PCT)
Prior art keywords
human interleukin
mutant proteins
mutant
proteins
interleukin
Prior art date
Application number
PCT/EP1999/008421
Other languages
English (en)
French (fr)
Other versions
WO2000027881A2 (de
Inventor
Heiner Apeler
Peter Reinemer
Angela Siegling
Original Assignee
Bayer Ag
Heiner Apeler
Peter Reinemer
Angela Siegling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Heiner Apeler, Peter Reinemer, Angela Siegling filed Critical Bayer Ag
Priority to AU26599/00A priority Critical patent/AU2659900A/en
Publication of WO2000027881A2 publication Critical patent/WO2000027881A2/de
Publication of WO2000027881A3 publication Critical patent/WO2000027881A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft Muteine vom humanen Interleukin 10 und dessen Verwendung als Arzneimittel.
PCT/EP1999/008421 1998-11-10 1999-11-04 Menschliche interleukin -10 mutantenproteine WO2000027881A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU26599/00A AU2659900A (en) 1998-11-10 1999-11-04 Human interleukin 10 mutant proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19851675.4 1998-11-10
DE19851675A DE19851675A1 (de) 1998-11-10 1998-11-10 Menschliche Interleukin-10 Mutantenproteine

Publications (2)

Publication Number Publication Date
WO2000027881A2 WO2000027881A2 (de) 2000-05-18
WO2000027881A3 true WO2000027881A3 (de) 2000-08-03

Family

ID=7887222

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/008421 WO2000027881A2 (de) 1998-11-10 1999-11-04 Menschliche interleukin -10 mutantenproteine

Country Status (3)

Country Link
AU (1) AU2659900A (de)
DE (1) DE19851675A1 (de)
WO (1) WO2000027881A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2620875B (en) 2019-04-19 2024-05-08 Synerkine Pharma B V A fusion protein comprising IL13
CR20230025A (es) * 2020-06-26 2023-10-05 Amgen Inc Muteínas de il-10 y proteínas de fusión de las mismas referencia cruzada a solicitudes relacionadas

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003411A1 (en) * 1993-07-26 1995-02-02 Schering Corporation Agonists and antagonists of human interleukin-10
WO1997026279A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003411A1 (en) * 1993-07-26 1995-02-02 Schering Corporation Agonists and antagonists of human interleukin-10
WO1997026279A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LU, PING ET AL: "Cloning and expression of canine interleukin-10", J. INTERFERON CYTOKINE RES. (1995), 15(12), 1103-9, 1995, XP000907296 *

Also Published As

Publication number Publication date
WO2000027881A2 (de) 2000-05-18
AU2659900A (en) 2000-05-29
DE19851675A1 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
EP0950665A4 (de) Veränderte physiologisch aktive proteine und medizinische verbindungen, die diese beinhalten
ITMI951021A0 (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU6307698A (en) Useful properties of human lactoferrin and variants thereof
AU3002195A (en) Fluoropolymer compositions and preparation and uses thereof
AU3840395A (en) Personal care composition
EP1818343A3 (de) Antikörper gegen humanes IL-12
AU7050994A (en) Human mutant tissue factor compositions useful as tissue factor antagonists
AU8905098A (en) Skin care compositions and use
CA2123315A1 (en) Therapeutic agents which are antagonists or partial agonists of human interleukin 4
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2672795A (en) Benzopyrans and their use as therapeutic agents
WO1996032403A3 (de) Neue cytosin- und cytidinderivate
AU2467395A (en) Novel ophthalmologic uses of protein c
AU7448198A (en) Compositions and means for the treatment of burns and other cutaneous traumas
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
HUP0003244A2 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
AU2554595A (en) Compositions and uses thereof in the diagnosis of psoriasis
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine
AU4636897A (en) Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses
HUP9901975A3 (en) Novel n,n'-bridged bis-indolyl-maleimides, their use as intermediates and pharmaceutical compositions containing them
AU2001297575A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase